|
[1]
|
Rizvi, S., Khan, S.A., Hallemeier, C.L., Kelley, R.K. and Gores, G.J. (2018) Cholangiocarcinoma—Evolving Concepts and Therapeutic Strategies. Nature Reviews Clinical Oncology, 15, 95-111. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
陶连元, 何小东, 高飞, 王磊, 张锋良, 龙志华, 等. 肝外胆管癌的临床病理与预后分析[J]. 肝胆外科杂志, 2011, 19(4): 251-253.
|
|
[3]
|
Wang, J.K., Hu, H.J., Shrestha, A., Ma, W.-J., Yang, Q., Liu, F., et al. (2017) Can Preoperative and Postoperative CA19-9 Levels Predict Survival and early Recurrence in Patients with Resectable Hilar Cholangiocarcinoma? Oncotarget, 8, 45335-45344. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Zhong, J.H., Huang, D.H. and Chen, Z.Y. (2017) Prognostic Role of Systemic Immune-Inflammation Index in Solid Tumors: A Systematic Review and Meta-Analysis. Oncotarget, 8, 75381-75388. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Akgul, O., Cetinkaya, E., Yalaza, M., Özden, S. and Tez, M. (2017) Prognostic Efficacy of Inflammation-Based Markers in Patients with Curative Colorectal Cancer Resection. World Journal of Gastrointestinal Oncology, 9, 300-307. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Choi, Y., Kim, J.W., Nam, K.H., Han, S.-H., Kim, J.-W., Ahn, S.-H., et al. (2017) Systemic Inflammation Is Associated with the Density of Immune Cells in the Tumor Microenvironment of Gastric Cancer. Gastric Cancer, 20, 602-611. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Dirkx, A.E.M., Egbrink, M., Wagstaff, J. and Griffioen, A.W. (2006) Monocyte/Macrophage Infiltration in Tumors: Modulators of Angiogenesis. Journal of Leukocyte Biology, 80, 1183-1196. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Lu, Y., Xin, D. and Wang, F. (2019) Predictive Significance of Preoperative Systemic Immune-Inflammation Index Determination in Postoperative Liver Metastasis of Colorectal Cancer. Oncotargets and Therapy, 12, 7791-7799. [Google Scholar] [CrossRef]
|
|
[9]
|
Macias, R.I. R., Kornek, M., Rodrigues, P.M., Paiva, N.A., Castro, R.E., Urban, S., et al. (2019) Diagnostic and Prognostic Biomarkers in Cholangiocarcinoma. Liver International, 39, 108-122. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Diakos, C.I., Charles, K.A., McMillan, D.C. and Clarke, S.J. (2014) Cancer-Related Inflammation and Treatment Effectiveness. Lancet Oncology, 15, E493-E503. [Google Scholar] [CrossRef]
|
|
[11]
|
Mantovani, A. (2009) CANCER Inflaming Metastasis. Nature, 457, 36-37. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Szebeni, G.J., Vizler, C., Kitajka, K. and Puskas, L.G. (2017) Inflammation and Cancer: Extra- and Intracellular Determinants of Tumor-Associated Macrophages as Tumor Promoters. Mediators of Inflammation, 2017, Article ID: 9294018. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Yilmaz, A., Mirili, C., Bilici, M. and Tekin, S.B. (2019) A Novel Predictor in Patients with Gastrointestinal Stromal Tumors: Systemic Immune-Inflammation Index (SII). Journal of Buon, 24, 2127-2135.
|
|
[14]
|
Hoshimoto, S., Hishinuma, S., Shirakawa, H., Tomikawa, M., Ozawa, I. and Ogata, Y. (2019) Association of Preoperative Platelet-to-Lymphocyte Ratio with Poor Outcome in Patients with Distal Cholangiocarcinoma. Oncology, 96, 290-298. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kumamoto, Y., Kaizu, T., Tajima, H., Nishizawa, N., Ei, S., Igarashi, K., et al. (2018) Neutrophil-to-Lymphocyte Ratio as a Predictor of Postoperative Morbidity in Patients with Distal Cholangiocarcinoma. Molecular and Clinical Oncology, 9, 362-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Terasaki, F., Sugiura, T., Okamura, Y., Ito, T., Yamamoto, Y., Ashida, R., et al. (2021) Systemic Immune-Inflammation Index as a Prognostic Marker for Distal Cholangiocarcinoma. Surgery Today, 51, 1602-1609. [Google Scholar] [CrossRef] [PubMed]
|